PLEURAL MESOTHELIOMA
Clinical trials for PLEURAL MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new PLEURAL MESOTHELIOMA trials appear
Sign up with your email to follow new studies for PLEURAL MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy plus chemo shows promise against rare lung cancer
Disease control OngoingThis study tests whether giving the immunotherapy drug pembrolizumab along with standard chemotherapy before surgery can improve outcomes for people with a rare cancer called pleural mesothelioma. About 41 adults with early-stage, treatable mesothelioma will receive the drug comb…
Matched conditions: PLEURAL MESOTHELIOMA
Phase: PHASE2 • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated May 26, 2026 10:12 UTC
-
New hope for rare cancers: drug trial targets hard-to-treat tumors
Disease control TerminatedThis study tests a drug called XmAb20717 in 140 adults with advanced rare cancers, including mesothelioma, cervical cancer, and Hodgkin's lymphoma. The goal is to see if the drug can shrink tumors and how safe it is. Participants must have measurable disease and be able to follow…
Matched conditions: PLEURAL MESOTHELIOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 18, 2026 12:01 UTC